kabutan

WAKAMOTO PHARMA, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Turns to Profit

Wed Feb 4, 2026 3:30 pm JST Earnings

4512 WAKAMOTO PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

WAKAMOTO PHARMACEUTICAL CO.,LTD. <4512> [TSE Std] announced its financial results after the market closed on February 4th (15:30). The ordinary profit/loss (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2026 (April to December) turned into a profit of 222 million yen (compared to a loss of 297 million yen in the same period last year). Progress toward the full-year plan of 250 million yen was 88.8%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit/loss for the January to March period (4Q) is expected to turn into a profit of 28 million yen (compared to a loss of 112 million yen in the same period last year).

In the most recent three-month period, from October to December (3Q), the ordinary profit/loss turned to a profit of 397 million yen (compared to a loss of 41 million yen in the same period last year). The operating profit/loss margin drastically improved from -3.3% in the same period last year to 13.0%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 5,586 -259 -225 -205 -5.9 ー Feb 5, 2024 J-GAAP
Apr - Dec, 2024 5,806 -341 -297 -19 -0.6 ー Feb 5, 2025 J-GAAP
Apr - Dec, 2025 7,310 187 222 215 6.2 88.8 Feb 4, 2026 J-GAAP
YoY +25.9% － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 3,978 -181 -153 205 5.9 3 May 15, 2025 J-GAAP
Oct - Mar, 2025 Guidance 5,618 395 425 334 9.6 3 Nov 6, 2025 J-GAAP
YoY +41.2% － － +62.9% +62.2%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 7,738 -195 -161 108 3.1 3 May 15, 2024 J-GAAP
Mar, 2025 7,789 -457 -409 64 1.9 3 May 15, 2025 J-GAAP
Mar, 2026 Guidance 10,000 200 250 200 5.8 3 May 15, 2025 J-GAAP
YoY +28.4% － － +212.5% +211.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 1,995 -65 -41 122 3.5 -3.3 Feb 5, 2025 J-GAAP
Jan - Mar, 2025 1,983 -116 -112 83 2.4 -5.8 May 15, 2025 J-GAAP
Apr - Jun, 2025 2,168 -143 -117 -108 -3.1 -6.6 Aug 5, 2025 J-GAAP
Jul - Sep, 2025 2,214 -52 -58 -26 -0.8 -2.3 Nov 6, 2025 J-GAAP
Oct - Dec, 2025 2,928 382 397 349 10.1 13.0 Feb 4, 2026 J-GAAP
YoY +46.8% － － +186.1% +184.7%

Related Articles